Aphria Impressive Q3 Financials Show Metrics Up Across The Board

Aphria Inc. (APHA) has reported its financial results for Q3 ended February 29, 2020.

Key Financial Highlights (All amounts are expressed in Canadian dollars, unless otherwise noted and are compared to Q2)

Net Revenue: +19.8%
- Cannabis Operations: +64.8%.
- Distribution Operations: +2.2%.
Gross Profit:
- Cannabis Operations: +24.1%.
- Distribution Operations: +3.6%.
Gross Margin:
- Cannabis Operations: decreased from 56.6% to 42.7%.
  - due to sale of cannabis purchased from another wholesaler & the sale of wholesale cannabis.
- Distribution Operations: increased to 12.9% from 12.7%.
Adj. EBITDA:
- Cannabis Operations: +78.1%.
- Distribution Operations: +23.8%.
Net Income: increased to $7.9 million from ($5.7 million).
Net Income/Share: increased to $0.03 from ($0.02).
Selling & Admin. Expenses: +3.5% due to:
- increase in head count.
- increase in transaction costs.
Cash/Cash Equiv.: +3.5%.
Working Capital: +10.5%.

Key Operational Highlights

Kilograms Sold: +98.4%.
All-in Cost of Goods Sold: -14.6%.
Average Retail Selling Price:
- Medical Cannabis: -27.3% to $6.41/gram.
- Adult-use Cannabis: +4.8% to $5.47/gram.

Forward Guidance: